Northland Capital Markets Upgrades Edwards Lifesciences (EW) to Outperform

November 8, 2016 9:26 AM EST
Get Alerts EW Hot Sheet
Price: $95.51 -0.81%

Rating Summary:
    27 Buy, 10 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade EW Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Northland Capital Markets upgraded Edwards Lifesciences (NYSE: EW) from Market Perform to Outperform with a price target of $105.00.

For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $91.34 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Upgrades

Add Your Comment